The analysis of the global R&D budget for health and medical sciences by country reveals significant disparities. In 2023, Sweden led with the highest government support at 33.15%, while Israel trailed at 0.61%. Recent trends show Sweden's R&D budget grew by 4.71%, while Poland experienced a decline of -2.45%. Over a five-year period, fluctuations such as Finland's drastic reduction of 26.18% and Latvia's increase of 2.57% indicate varied national priorities.
Looking forward, keep an eye on:
- Geopolitical tensions that may impact funding allocation.
- Evolving health challenges necessitating increased collaborative R&D efforts globally.
- The role of government policies in shaping future R&D investments across countries.
Top countries in R&D Budget for Health and Medical Sciences by Country
| # | 10 Countries | Percent of Total Government Support | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Sweden | 33.15 | 2023 | +4.93% | +4.71% | View data |
| 2 | 2 United States | 26.09 | 2023 | +0.18% | +0.6% | View data |
| 3 | 3 Spain | 20.11 | 2023 | +0.48% | +0.96% | View data |
| 4 | 4 Latvia | 16.43 | 2023 | +2.19% | +2.57% | View data |
| 5 | 5 Australia | 15.89 | 2023 | +1.84% | +2.78% | View data |
| 6 | 6 Germany | 15.68 | 2023 | +0.52% | +0.45% | View data |
| 7 | 7 Denmark | 14.99 | 2023 | +1.51% | +1.35% | View data |
| 8 | 8 Slovenia | 13.23 | 2023 | +2.7% | +2.71% | View data |
| 9 | 9 Poland | 10.57 | 2023 | -1.19% | -2.45% | View data |
| 10 | 10 France | 10.34 | 2023 | +0.045% | +0.47% | View data |
